Recon: EMA to discuss Pfizer, Moderna bivalent boosters on 1 September; AstraZeneca on the hunt for new deals
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy